Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
Erythrodermic psoriasis (EP) is a rare and severe form of psoriasis that affects 1 to 2.25% of patients, increasing mortality risk. To date, very few therapies have been approved for the treatment of this condition. Recently, biological therapies which specifically target inflammatory cytokines have...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
AboutScience Srl,
2022-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|